Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Cancer Research Society Doctoral Research Awards - CBCI

University of British Columbia

$35,000.00

Repurposing the angiotensin II receptor blocker Telmisartan to promote anti-tumour immune responses

EF 2024-25

Programme
Cancer Research Society Doctoral Research Awards - CBCI
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
511207
Name
Clark Meredith
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Cancer Research Society Inc.; Cancer Research Society Inc.
Instname2
Cancer Research
Prcname2
Special Cases
Projecttitle
Repurposing the angiotensin II receptor blocker Telmisartan to promote anti-tumour immune responses
Programtype2
Miscellaneous Programs
Orgnameinp2
University of British Columbia
Cihramount2
$35,000
Cihrequipment2
$0
Programname2
Cancer Research Society Doctoral Research Awards - CBCI
Keyworddelim
Angiotensin Ii; Cancer; Immune Response
Competitiondate
202404
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Clark, Meredith
Approvedterm
2 ans 0 mois
Cihrcontribution2
ICR~ $35,000~ $0~